Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303) Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Biomarkers, Tumor
  • Pancreatic Neoplasms

abstract

  • AACT may be a useful prognostic marker in patients with advanced stage pancreatic carcinoma, although additional validation studies are needed.

publication date

  • January 15, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3184330

Digital Object Identifier (DOI)

  • 10.1002/cncr.26270

PubMed ID

  • 21713765

Additional Document Info

start page

  • 571

end page

  • 8

volume

  • 118

number

  • 2